×

Cara Therapeutics to Webcast Presentation at 13th Annual Needham Healthcare Conference

SHELTON, Conn., April 2, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors, announced today that Dr. Derek Chalmers, President and CEO, will present a company overview at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 9:20 a.m. ET in New York City.

A live webcast of the presentation can be accessed under "Events and Presentations" in the News & Investors section of the Company's website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body's peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

CONTACT: Jesse Baumgartner, Stern Investor Relations, 212-362-1200 Tony Plohoros, 6 Degrees PR, 908-940-0135

Source:Cara Therapeutics, Inc.